Hemagen Diagnostics (Hemagen Diagnostics) Accounts Payable & Accrued Expense : $0.95 Mil (As of Sep. 2012)

View and export this data going back to . Start your Free Trial

What is Hemagen Diagnostics Accounts Payable & Accrued Expense?

Hemagen Diagnostics's quarterly accounts payable & accrued expense increased from Mar. 2012 ($0.86 Mil) to Jun. 2012 ($0.90 Mil) and increased from Jun. 2012 ($0.90 Mil) to Sep. 2012 ($0.95 Mil).

Hemagen Diagnostics's annual accounts payable & accrued expense increased from Sep. 2010 ($0.74 Mil) to Sep. 2011 ($0.82 Mil) and increased from Sep. 2011 ($0.82 Mil) to Sep. 2012 ($0.95 Mil).

Hemagen Diagnostics Accounts Payable & Accrued Expense Historical Data

The historical data trend for Hemagen Diagnostics's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hemagen Diagnostics Accounts Payable & Accrued Expense Chart

Hemagen Diagnostics Annual Data

Trend

Sep03

Sep04

Sep05

Sep06

Sep07

Sep08

Sep09

Sep10

Sep11

Sep12

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

1.13

0.97

0.74

0.82

0.95

Hemagen Diagnostics Quarterly Data
	Dec07	Mar08	Jun08	Sep08	Dec08	Mar09	Jun09	Sep09	Dec09	Mar10	Jun10	Sep10	Dec10	Mar11	Jun11	Sep11	Dec11	Mar12	Jun12	Sep12
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial															0.82	0.83	0.86	0.90	0.95

Hemagen Diagnostics Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Hemagen Diagnostics (Hemagen Diagnostics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Hemagen Diagnostics Inc (OTCPK:HMGN) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

9033 Red Branch Road, Columbia, MD, USA, 21045

Website

http://www.hemagen.com

Hemagen Diagnostics Inc is a biotechnology company. It develops, manufactures and markets Food and Drug Administration cleared proprietary medical diagnostic test kits and components. The company's Virgo line of Immunoassays are used to aid in the diagnosis of autoimmune and infectious diseases and acute-phase proteins. The assays utilize multiple technologies including ELISA, immunofluorescence (IFA) and hemagglutination (HA). Its products include ANA Screen ELISA 96 Test System, Rubella IgG ELISA 96 Test System, AMA IFA 48 Test System and others.

Executives

Howard F Curd

director

Hemagen Diagnostics (Hemagen Diagnostics) Headlines

No Headlines